Depression and anxiety are common comorbidities in breast cancer patients. As a results patients with breast cancer may require treatment with antidepressants. For this reason, it is of clinical importance to have knowledge of drug interactions between antidepressants and breast cancer treatment Tamoxifen.
Tamoxifen is a selective estrogen receptor modulator (SERM). It has been FDA approved for the treatment of both early and advanced estrogen receptor-positive breast cancer in pre-and post-menopausal women and in men. Tamoxifen is also FDA approved for the prevention of breast cancer in women at high risk for breast cancer.
Let’s begin by answering this question first: